Navigation Links
New strategy to weaken traumatic memories
Date:3/17/2009

Philadelphia, PA, 17 March 2009 Imagine that you have been in combat and that you have watched your closest friend die in front of you. The memory of that event may stay with you, troubling you for the rest of your life. Posttraumatic stress disorder (PTSD) is among the most common and disabling psychiatric casualties of combat and other extremely stressful situations. People suffering from PTSD often suffer from vivid intrusive memories of their traumas. Current medications are often ineffective in controlling these symptoms and so novel treatments are needed urgently. In the February 1st issue of Biological Psychiatry, published by Elsevier, a group of basic scientists shed new light on the biology of stress effects upon memory formation. In so doing, they suggest new approaches to the treatment of the distress related to traumatic memories. Their work is based on the study of a drug, RU38486, that blocks the effects of the stress hormone cortisol.

Using an animal model of traumatic memory, investigators at the Mount Sinai School of Medicine show that treatment with RU38486 selectively reduces stress-related memories, leaving other memories unchanged. They also found that the effectiveness of the treatment is a function of the intensity of the initial "trauma." Although this particular study was performed in rats, their findings help to set the stage for trials in humans. Cristina Alberini, Ph.D., corresponding author on this article, explains how their findings will translate into developing clinical parameters: "First, the drug should be administered shortly before or after recalling the memory of the traumatic event. Second, one or two treatments are sufficient to maximally disrupt the memory. Third, the effect is long lasting and selective for the recalled memory. Finally, the time elapsing between the traumatic experience and the treatment seems to be an important parameter for obtaining the most efficacious treatment."


'/>"/>
Contact: Jayne Dawkins
ja.dawkins@elsevier.com
215-239-3674
Elsevier
Source:Eurekalert

Page: 1 2

Related medicine news :

1. AWT Management Announce Aggressive Growth and Acquisition Strategy
2. Coalition America Announces Addition of Mollie Gordon Brown as Chief Strategy Officer
3. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
4. More Than 100 Organizations Call for a National AIDS Strategy to End the Epidemic in the United States
5. Penn Veterinary Medicine report new strategy to create genetically modified animals
6. Novel strategy under study for aggressive leukemia
7. AIDS Action Council Commends Senator Edwards for Endorsing a National HIV/AIDS Strategy
8. Blue Shield of California Names Vincent Coppola Vice President of Strategy and Business Development
9. Scientific Publications Strategy & Delivery Shifts from Marketing to Medical
10. Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy
11. Computerized training of working memory is a promising therapeutic strategy in ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... 2015 , ... The New Foundation AZ recently started a massive ... cost the 501(c) organization nearly $1 million, will both update the facilities’ design and ... it down to the studs,” said Geraldine Leary, the New Foundation AZ chief executive ...
(Date:7/29/2015)... ... July 29, 2015 , ... People that are passionate about gardening and those ... a vertical “garden tower” and enhanced mineral product for growing ideal crops. , ... a porch, balcony, or rooftop – can hold up to 100 plants in just ...
(Date:7/29/2015)... ... July 29, 2015 , ... Hernia repairs have always ... a result. Information provided by the National Center for Health Statistics indicates that ... million new cases are reported annually. While the only effective treatment for a hernia ...
(Date:7/28/2015)... ... July 29, 2015 , ... Talking About Your Product Pipeline:, ... 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/productpipeline , When a company has ... can’t — say about it is tightly regulated by the FDA. , At the ...
(Date:7/28/2015)... Jordan, Utah (PRWEB) , ... July 28, 2015 ... ... Center West Valley Campus have received the Get With The Guidelines®-Stroke Gold Plus ... for excellence in patient care and outcomes. , The Get With The ...
Breaking Medicine News(10 mins):Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 2Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 2Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 3
... to Help Make Healthy Choices on the Job This ... is right around the,corner and for many people that ... back on calories and finding time to exercise can,seem ... reports,that 45 percent of workers have gained weight at ...
... May 14 /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: ... of medical devices in China with a rapidly ... Mindray,s,executive vice president of strategic development and Ms. ... the Oppenheimer 2nd Annual,China Dragon Call Conference to ...
... GENEVA, Il., May 14 Media representatives,from accredited ... surgeries and interview an esteemed international panel of ... hair surgery workshop,hosted by the International Society of ... (IDI)., World-renown hair restoration physicians will gather ...
... provides solutions for hair loss and self esteem, SAUSALITO, ... learned that a young woman was afraid to go to ... her, she took action.,Peggy donated two of her custom-made hair ... Areata Foundation,s Annual Conference in,Louisville, KY -- and raised the ...
... Treatment for Hemophilia With ... PRINCETON, N.J., May 13 Novo Nordisk ... (FDA) has approved,NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] ... product available,for the treatment of bleeding episodes in ...
... electronic bingo to fulfill the unmet needs of ... individuals, families, children and communities, SACRAMENTO, Calif., ... its formation to advocate for the use of,traditional and ... consistent funding source for nonprofit charities. Founding,organizations for this ...
Cached Medicine News:Health News:Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds 2Health News:Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds 3Health News:Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds 4Health News:Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference 2Health News:International Society of Hair Restoration Surgery and Istituto Dermopatico dell'Immacolata Host Made In Italy: Hair Restoration Live Video Surgery Workshop May 30 - June 1, 2008, Rome, Italy 2Health News:Teen Girl Loses Hair But Gains Support 2Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 2Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 3Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 4Health News:Charities Form Alliance to Preserve and Improve Charity Bingo 2
(Date:7/28/2015)... 2015  SeraCare Life Sciences, a leading partner ... at the American Association of Clinical Chemistry (AACC) ... with the University of California, San Francisco (UCSF) ... 18 (T18) and Trisomy 13 (T13) trophoblast cell ... reference materials for Non-Invasive Prenatal Testing (NIPT) of ...
(Date:7/28/2015)... 28, 2015 At the 2015 ... Association recognized 15 winners in the categories of ... across multiple vertical markets. ContextMedia:Health proudly took ... for its success with its first-to-market Patient ... ContextMedia:Health, the leading provider of digital solutions ...
(Date:7/28/2015)... Transparency Market Research (TMR) has announced ... Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, ... to this report, the global cancer diagnostics market is expected ... period of 2014 to 2020. In 2013, the global cancer ... to be worth US$168,649.3 million by 2020.The increasing prevalence of ...
Breaking Medicine Technology:SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3ContextMedia:Health Receives Top Award at the ICX Association Excellence Awards 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4
... N.J., Oct. 27 Laureate Pharma, Inc., ... announced today that they have entered into ... AV-203, AVEO Pharmaceutical,s (Cambridge, MA) novel monoclonal ... include process development, protein production, purification and ...
... Samplify Systems, Inc., a leading ... solutions for the medical imaging market, today introduces ... on Samplify,s AutoFocus™ beamforming technology, the SMK9130 is ... end, from probe connector to PCIe connector.  The ...
Cached Medicine Technology:Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals' Antibody Therapeutic 2Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months 2Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months 3
... for use with Coulter® Ac.T™ three-part ... diluent, lysing agent, cleaning agent and ... package configuration includes diluent, lysing agent, ... shelf life is one year from ...
... reagent manufactured for the ... hemoglobin and white blood ... is manufactured specifically for ... CELL-DYN® 1700. The shelf ...
... an enzymatic cleanser for automated and semi-automated ... 475ml bottle has a flip-top spout for ... that require manual addition of an enzyme ... of this product. The shelf life of ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Medicine Products: